/
BIT.AX
No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Biotron Limited
Biotron Limited is an Australian biotechnology firm dedicated to the creation and market introduction of small molecule therapies designed to combat a range of viral illnesses. Its flagship antiviral compound, BIT225, is currently undergoing Phase II clinical evaluations for addressing infections caused by SARS-CoV-2, HIV-1, and the hepatitis C virus. Established in 1999, the company operates from its main office in Sydney, Australia.
www.biotron.com.au- Employees
- 4
- IPO / List date
- Jan 23, 2001
- HQ
- AU
Held by traders on TradeandTell
No one on the platform currently holds BIT.AX.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BIT.AX as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded BIT.AX yet.